nodes	percent_of_prediction	percent_of_DWPC	metapath
Neostigmine—ABCB1—Dactinomycin—sarcoma	0.197	0.289	CbGbCtD
Neostigmine—ABCB1—Mitoxantrone—sarcoma	0.176	0.259	CbGbCtD
Neostigmine—ABCB1—Vincristine—sarcoma	0.121	0.178	CbGbCtD
Neostigmine—ABCB1—Etoposide—sarcoma	0.111	0.163	CbGbCtD
Neostigmine—ABCB1—Doxorubicin—sarcoma	0.0757	0.111	CbGbCtD
Neostigmine—Respiratory arrest—Thiotepa—sarcoma	0.00996	0.0339	CcSEcCtD
Neostigmine—BCHE—diaphragm—sarcoma	0.00984	0.38	CbGeAlD
Neostigmine—Abdominal cramps—Vincristine—sarcoma	0.00576	0.0196	CcSEcCtD
Neostigmine—Paralysis—Vincristine—sarcoma	0.00559	0.019	CcSEcCtD
Neostigmine—Nystagmus—Vincristine—sarcoma	0.00544	0.0185	CcSEcCtD
Neostigmine—Cardiovascular disorder—Etoposide—sarcoma	0.00358	0.0122	CcSEcCtD
Neostigmine—Chest discomfort—Etoposide—sarcoma	0.00356	0.0121	CcSEcCtD
Neostigmine—Coma—Vincristine—sarcoma	0.00355	0.0121	CcSEcCtD
Neostigmine—Cardiac arrest—Thiotepa—sarcoma	0.00303	0.0103	CcSEcCtD
Neostigmine—Lacrimation—Epirubicin—sarcoma	0.003	0.0102	CcSEcCtD
Neostigmine—Lacrimation—Doxorubicin—sarcoma	0.00278	0.00945	CcSEcCtD
Neostigmine—Cardiac arrest—Vincristine—sarcoma	0.00268	0.00913	CcSEcCtD
Neostigmine—Paralysis—Epirubicin—sarcoma	0.00254	0.00864	CcSEcCtD
Neostigmine—Nystagmus—Epirubicin—sarcoma	0.00247	0.00841	CcSEcCtD
Neostigmine—Paralysis—Doxorubicin—sarcoma	0.00235	0.008	CcSEcCtD
Neostigmine—Sweating increased—Mitoxantrone—sarcoma	0.00231	0.00787	CcSEcCtD
Neostigmine—Nystagmus—Doxorubicin—sarcoma	0.00229	0.00778	CcSEcCtD
Neostigmine—Urinary tract disorder—Thiotepa—sarcoma	0.00217	0.00739	CcSEcCtD
Neostigmine—Cardiac arrest—Etoposide—sarcoma	0.00217	0.00739	CcSEcCtD
Neostigmine—Connective tissue disorder—Thiotepa—sarcoma	0.00216	0.00736	CcSEcCtD
Neostigmine—Urethral disorder—Thiotepa—sarcoma	0.00216	0.00734	CcSEcCtD
Neostigmine—Drowsiness—Mitoxantrone—sarcoma	0.00212	0.0072	CcSEcCtD
Neostigmine—Cramp muscle—Etoposide—sarcoma	0.00206	0.007	CcSEcCtD
Neostigmine—Flushing—Dactinomycin—sarcoma	0.00203	0.0069	CcSEcCtD
Neostigmine—Cardiovascular disorder—Epirubicin—sarcoma	0.00201	0.00683	CcSEcCtD
Neostigmine—Mediastinal disorder—Thiotepa—sarcoma	0.00198	0.00675	CcSEcCtD
Neostigmine—Arrhythmia—Thiotepa—sarcoma	0.00197	0.00669	CcSEcCtD
Neostigmine—Bronchospasm—Etoposide—sarcoma	0.00194	0.00661	CcSEcCtD
Neostigmine—Bradycardia—Mitoxantrone—sarcoma	0.00193	0.00658	CcSEcCtD
Neostigmine—Mental disorder—Thiotepa—sarcoma	0.00193	0.00656	CcSEcCtD
Neostigmine—Urinary tract disorder—Vincristine—sarcoma	0.00193	0.00656	CcSEcCtD
Neostigmine—Sweating increased—Etoposide—sarcoma	0.00192	0.00655	CcSEcCtD
Neostigmine—Connective tissue disorder—Vincristine—sarcoma	0.00192	0.00653	CcSEcCtD
Neostigmine—Lacrimation increased—Epirubicin—sarcoma	0.00191	0.00652	CcSEcCtD
Neostigmine—Urethral disorder—Vincristine—sarcoma	0.00191	0.00651	CcSEcCtD
Neostigmine—Dysarthria—Epirubicin—sarcoma	0.00187	0.00635	CcSEcCtD
Neostigmine—Cardiovascular disorder—Doxorubicin—sarcoma	0.00186	0.00632	CcSEcCtD
Neostigmine—Atrioventricular block—Epirubicin—sarcoma	0.00182	0.00619	CcSEcCtD
Neostigmine—Lacrimation increased—Doxorubicin—sarcoma	0.00177	0.00603	CcSEcCtD
Neostigmine—Agitation—Thiotepa—sarcoma	0.00176	0.00599	CcSEcCtD
Neostigmine—Mediastinal disorder—Vincristine—sarcoma	0.00176	0.00598	CcSEcCtD
Neostigmine—Dysarthria—Doxorubicin—sarcoma	0.00173	0.00587	CcSEcCtD
Neostigmine—Salivary hypersecretion—Epirubicin—sarcoma	0.00171	0.00583	CcSEcCtD
Neostigmine—Mental disorder—Vincristine—sarcoma	0.00171	0.00582	CcSEcCtD
Neostigmine—Arrhythmia—Mitoxantrone—sarcoma	0.0017	0.00578	CcSEcCtD
Neostigmine—Atrioventricular block—Doxorubicin—sarcoma	0.00168	0.00573	CcSEcCtD
Neostigmine—Convulsion—Thiotepa—sarcoma	0.00166	0.00565	CcSEcCtD
Neostigmine—Arthralgia—Thiotepa—sarcoma	0.00163	0.00555	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00162	0.00551	CcSEcCtD
Neostigmine—Coma—Epirubicin—sarcoma	0.00161	0.00549	CcSEcCtD
Neostigmine—Salivary hypersecretion—Doxorubicin—sarcoma	0.00159	0.0054	CcSEcCtD
Neostigmine—Urinary tract disorder—Etoposide—sarcoma	0.00156	0.00531	CcSEcCtD
Neostigmine—Agitation—Vincristine—sarcoma	0.00156	0.00531	CcSEcCtD
Neostigmine—Urethral disorder—Etoposide—sarcoma	0.00155	0.00527	CcSEcCtD
Neostigmine—Nervous system disorder—Thiotepa—sarcoma	0.00153	0.00522	CcSEcCtD
Neostigmine—Tachycardia—Thiotepa—sarcoma	0.00153	0.00519	CcSEcCtD
Neostigmine—Skin disorder—Thiotepa—sarcoma	0.00152	0.00517	CcSEcCtD
Neostigmine—Coma—Doxorubicin—sarcoma	0.00149	0.00508	CcSEcCtD
Neostigmine—Convulsion—Vincristine—sarcoma	0.00147	0.00501	CcSEcCtD
Neostigmine—Flushing—Etoposide—sarcoma	0.00147	0.00499	CcSEcCtD
Neostigmine—Convulsion—Mitoxantrone—sarcoma	0.00143	0.00488	CcSEcCtD
Neostigmine—Mediastinal disorder—Etoposide—sarcoma	0.00142	0.00485	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00142	0.00485	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00141	0.00481	CcSEcCtD
Neostigmine—Arthralgia—Mitoxantrone—sarcoma	0.00141	0.00479	CcSEcCtD
Neostigmine—Somnolence—Thiotepa—sarcoma	0.00139	0.00473	CcSEcCtD
Neostigmine—Anaphylactic shock—Vincristine—sarcoma	0.00139	0.00472	CcSEcCtD
Neostigmine—ACHE—tendon—sarcoma	0.00138	0.0534	CbGeAlD
Neostigmine—Nervous system disorder—Vincristine—sarcoma	0.00136	0.00463	CcSEcCtD
Neostigmine—Anaphylactic shock—Mitoxantrone—sarcoma	0.00135	0.00459	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Thiotepa—sarcoma	0.00135	0.00459	CcSEcCtD
Neostigmine—Hyperhidrosis—Vincristine—sarcoma	0.00134	0.00456	CcSEcCtD
Neostigmine—Shock—Mitoxantrone—sarcoma	0.00133	0.00452	CcSEcCtD
Neostigmine—Muscle spasms—Etoposide—sarcoma	0.00132	0.0045	CcSEcCtD
Neostigmine—Tachycardia—Mitoxantrone—sarcoma	0.00132	0.00448	CcSEcCtD
Neostigmine—Skin disorder—Mitoxantrone—sarcoma	0.00131	0.00446	CcSEcCtD
Neostigmine—Hyperhidrosis—Mitoxantrone—sarcoma	0.00131	0.00444	CcSEcCtD
Neostigmine—Hypotension—Vincristine—sarcoma	0.0013	0.00441	CcSEcCtD
Neostigmine—Osteoarthritis—Epirubicin—sarcoma	0.00128	0.00436	CcSEcCtD
Neostigmine—Gastrointestinal pain—Thiotepa—sarcoma	0.00128	0.00435	CcSEcCtD
Neostigmine—Gastrointestinal pain—Dactinomycin—sarcoma	0.00127	0.00432	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Vincristine—sarcoma	0.00126	0.0043	CcSEcCtD
Neostigmine—Hypotension—Mitoxantrone—sarcoma	0.00126	0.00429	CcSEcCtD
Neostigmine—Insomnia—Vincristine—sarcoma	0.00125	0.00427	CcSEcCtD
Neostigmine—Urticaria—Thiotepa—sarcoma	0.00124	0.00423	CcSEcCtD
Neostigmine—Abdominal pain—Thiotepa—sarcoma	0.00124	0.00421	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00123	0.00419	CcSEcCtD
Neostigmine—Abdominal pain—Dactinomycin—sarcoma	0.00123	0.00417	CcSEcCtD
Neostigmine—Cardiac arrest—Epirubicin—sarcoma	0.00122	0.00414	CcSEcCtD
Neostigmine—Loss of consciousness—Etoposide—sarcoma	0.00121	0.00412	CcSEcCtD
Neostigmine—Dyspnoea—Mitoxantrone—sarcoma	0.0012	0.0041	CcSEcCtD
Neostigmine—Somnolence—Mitoxantrone—sarcoma	0.0012	0.00408	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Vincristine—sarcoma	0.0012	0.00407	CcSEcCtD
Neostigmine—BCHE—myometrium—sarcoma	0.0012	0.0462	CbGeAlD
Neostigmine—Convulsion—Etoposide—sarcoma	0.00119	0.00406	CcSEcCtD
Neostigmine—Osteoarthritis—Doxorubicin—sarcoma	0.00119	0.00403	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00116	0.00396	CcSEcCtD
Neostigmine—Hypersensitivity—Thiotepa—sarcoma	0.00115	0.00392	CcSEcCtD
Neostigmine—ACHE—testis—sarcoma	0.00115	0.0442	CbGeAlD
Neostigmine—Hypersensitivity—Dactinomycin—sarcoma	0.00114	0.00389	CcSEcCtD
Neostigmine—Gastrointestinal pain—Vincristine—sarcoma	0.00113	0.00386	CcSEcCtD
Neostigmine—Cardiac arrest—Doxorubicin—sarcoma	0.00113	0.00383	CcSEcCtD
Neostigmine—Anaphylactic shock—Etoposide—sarcoma	0.00112	0.00382	CcSEcCtD
Neostigmine—Asthenia—Thiotepa—sarcoma	0.00112	0.00382	CcSEcCtD
Neostigmine—Asthenia—Dactinomycin—sarcoma	0.00111	0.00379	CcSEcCtD
Neostigmine—Pruritus—Thiotepa—sarcoma	0.00111	0.00376	CcSEcCtD
Neostigmine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.0011	0.00376	CcSEcCtD
Neostigmine—Tachycardia—Etoposide—sarcoma	0.0011	0.00373	CcSEcCtD
Neostigmine—Abdominal pain—Vincristine—sarcoma	0.0011	0.00373	CcSEcCtD
Neostigmine—Skin disorder—Etoposide—sarcoma	0.00109	0.00371	CcSEcCtD
Neostigmine—Hyperhidrosis—Etoposide—sarcoma	0.00109	0.00369	CcSEcCtD
Neostigmine—BCHE—seminal vesicle—sarcoma	0.00108	0.0417	CbGeAlD
Neostigmine—Urticaria—Mitoxantrone—sarcoma	0.00107	0.00365	CcSEcCtD
Neostigmine—Diarrhoea—Thiotepa—sarcoma	0.00107	0.00364	CcSEcCtD
Neostigmine—Abdominal pain—Mitoxantrone—sarcoma	0.00107	0.00363	CcSEcCtD
Neostigmine—Diarrhoea—Dactinomycin—sarcoma	0.00106	0.00361	CcSEcCtD
Neostigmine—Hypotension—Etoposide—sarcoma	0.00105	0.00357	CcSEcCtD
Neostigmine—Dizziness—Thiotepa—sarcoma	0.00103	0.00352	CcSEcCtD
Neostigmine—BCHE—hematopoietic system—sarcoma	0.00103	0.0397	CbGeAlD
Neostigmine—Pollakiuria—Epirubicin—sarcoma	0.00102	0.00348	CcSEcCtD
Neostigmine—Hypersensitivity—Vincristine—sarcoma	0.00102	0.00348	CcSEcCtD
Neostigmine—Dyspnoea—Etoposide—sarcoma	0.001	0.00341	CcSEcCtD
Neostigmine—Somnolence—Etoposide—sarcoma	0.000999	0.0034	CcSEcCtD
Neostigmine—Hypersensitivity—Mitoxantrone—sarcoma	0.000995	0.00338	CcSEcCtD
Neostigmine—Asthenia—Vincristine—sarcoma	0.000995	0.00338	CcSEcCtD
Neostigmine—Vomiting—Thiotepa—sarcoma	0.000994	0.00338	CcSEcCtD
Neostigmine—Drowsiness—Epirubicin—sarcoma	0.000987	0.00336	CcSEcCtD
Neostigmine—Vomiting—Dactinomycin—sarcoma	0.000987	0.00336	CcSEcCtD
Neostigmine—Rash—Thiotepa—sarcoma	0.000986	0.00335	CcSEcCtD
Neostigmine—Dermatitis—Thiotepa—sarcoma	0.000985	0.00335	CcSEcCtD
Neostigmine—Headache—Thiotepa—sarcoma	0.00098	0.00333	CcSEcCtD
Neostigmine—Rash—Dactinomycin—sarcoma	0.000979	0.00333	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Etoposide—sarcoma	0.00097	0.0033	CcSEcCtD
Neostigmine—Asthenia—Mitoxantrone—sarcoma	0.000969	0.0033	CcSEcCtD
Neostigmine—Diarrhoea—Vincristine—sarcoma	0.000949	0.00323	CcSEcCtD
Neostigmine—Pollakiuria—Doxorubicin—sarcoma	0.000946	0.00322	CcSEcCtD
Neostigmine—Nausea—Thiotepa—sarcoma	0.000929	0.00316	CcSEcCtD
Neostigmine—Diarrhoea—Mitoxantrone—sarcoma	0.000924	0.00314	CcSEcCtD
Neostigmine—Nausea—Dactinomycin—sarcoma	0.000922	0.00314	CcSEcCtD
Neostigmine—Gastrointestinal pain—Etoposide—sarcoma	0.000918	0.00312	CcSEcCtD
Neostigmine—Dizziness—Vincristine—sarcoma	0.000917	0.00312	CcSEcCtD
Neostigmine—Drowsiness—Doxorubicin—sarcoma	0.000913	0.00311	CcSEcCtD
Neostigmine—BCHE—smooth muscle tissue—sarcoma	0.000905	0.0349	CbGeAlD
Neostigmine—Bradycardia—Epirubicin—sarcoma	0.000902	0.00307	CcSEcCtD
Neostigmine—BCHE—skin of body—sarcoma	0.000893	0.0345	CbGeAlD
Neostigmine—Urticaria—Etoposide—sarcoma	0.000892	0.00304	CcSEcCtD
Neostigmine—Abdominal pain—Etoposide—sarcoma	0.000888	0.00302	CcSEcCtD
Neostigmine—Vomiting—Vincristine—sarcoma	0.000882	0.003	CcSEcCtD
Neostigmine—Urinary tract disorder—Epirubicin—sarcoma	0.000875	0.00298	CcSEcCtD
Neostigmine—Rash—Vincristine—sarcoma	0.000874	0.00297	CcSEcCtD
Neostigmine—Dermatitis—Vincristine—sarcoma	0.000873	0.00297	CcSEcCtD
Neostigmine—Connective tissue disorder—Epirubicin—sarcoma	0.000871	0.00296	CcSEcCtD
Neostigmine—Urethral disorder—Epirubicin—sarcoma	0.000869	0.00296	CcSEcCtD
Neostigmine—Headache—Vincristine—sarcoma	0.000869	0.00296	CcSEcCtD
Neostigmine—Vomiting—Mitoxantrone—sarcoma	0.000859	0.00292	CcSEcCtD
Neostigmine—Rash—Mitoxantrone—sarcoma	0.000851	0.0029	CcSEcCtD
Neostigmine—Dermatitis—Mitoxantrone—sarcoma	0.000851	0.00289	CcSEcCtD
Neostigmine—Headache—Mitoxantrone—sarcoma	0.000846	0.00288	CcSEcCtD
Neostigmine—Bradycardia—Doxorubicin—sarcoma	0.000835	0.00284	CcSEcCtD
Neostigmine—ACHE—lymph node—sarcoma	0.00083	0.0321	CbGeAlD
Neostigmine—Hypersensitivity—Etoposide—sarcoma	0.000828	0.00282	CcSEcCtD
Neostigmine—Nausea—Vincristine—sarcoma	0.000824	0.0028	CcSEcCtD
Neostigmine—Flushing—Epirubicin—sarcoma	0.000822	0.0028	CcSEcCtD
Neostigmine—Urinary tract disorder—Doxorubicin—sarcoma	0.00081	0.00276	CcSEcCtD
Neostigmine—Asthenia—Etoposide—sarcoma	0.000806	0.00274	CcSEcCtD
Neostigmine—Connective tissue disorder—Doxorubicin—sarcoma	0.000806	0.00274	CcSEcCtD
Neostigmine—Urethral disorder—Doxorubicin—sarcoma	0.000804	0.00273	CcSEcCtD
Neostigmine—Nausea—Mitoxantrone—sarcoma	0.000802	0.00273	CcSEcCtD
Neostigmine—Mediastinal disorder—Epirubicin—sarcoma	0.000799	0.00272	CcSEcCtD
Neostigmine—Pruritus—Etoposide—sarcoma	0.000795	0.0027	CcSEcCtD
Neostigmine—Arrhythmia—Epirubicin—sarcoma	0.000792	0.00269	CcSEcCtD
Neostigmine—BCHE—cardiac atrium—sarcoma	0.00078	0.0301	CbGeAlD
Neostigmine—Mental disorder—Epirubicin—sarcoma	0.000776	0.00264	CcSEcCtD
Neostigmine—BCHE—uterus—sarcoma	0.000776	0.03	CbGeAlD
Neostigmine—Diarrhoea—Etoposide—sarcoma	0.000769	0.00261	CcSEcCtD
Neostigmine—Flushing—Doxorubicin—sarcoma	0.000761	0.00259	CcSEcCtD
Neostigmine—Flatulence—Epirubicin—sarcoma	0.00076	0.00259	CcSEcCtD
Neostigmine—Dizziness—Etoposide—sarcoma	0.000743	0.00253	CcSEcCtD
Neostigmine—Muscle spasms—Epirubicin—sarcoma	0.000742	0.00252	CcSEcCtD
Neostigmine—Mediastinal disorder—Doxorubicin—sarcoma	0.000739	0.00251	CcSEcCtD
Neostigmine—Arrhythmia—Doxorubicin—sarcoma	0.000733	0.00249	CcSEcCtD
Neostigmine—Mental disorder—Doxorubicin—sarcoma	0.000718	0.00244	CcSEcCtD
Neostigmine—Vomiting—Etoposide—sarcoma	0.000714	0.00243	CcSEcCtD
Neostigmine—Agitation—Epirubicin—sarcoma	0.000709	0.00241	CcSEcCtD
Neostigmine—Rash—Etoposide—sarcoma	0.000708	0.00241	CcSEcCtD
Neostigmine—Dermatitis—Etoposide—sarcoma	0.000708	0.00241	CcSEcCtD
Neostigmine—Headache—Etoposide—sarcoma	0.000704	0.00239	CcSEcCtD
Neostigmine—Flatulence—Doxorubicin—sarcoma	0.000703	0.00239	CcSEcCtD
Neostigmine—Syncope—Epirubicin—sarcoma	0.000692	0.00235	CcSEcCtD
Neostigmine—Muscle spasms—Doxorubicin—sarcoma	0.000686	0.00233	CcSEcCtD
Neostigmine—Loss of consciousness—Epirubicin—sarcoma	0.000678	0.00231	CcSEcCtD
Neostigmine—Convulsion—Epirubicin—sarcoma	0.000668	0.00227	CcSEcCtD
Neostigmine—Nausea—Etoposide—sarcoma	0.000667	0.00227	CcSEcCtD
Neostigmine—BCHE—bone marrow—sarcoma	0.000658	0.0254	CbGeAlD
Neostigmine—Arthralgia—Epirubicin—sarcoma	0.000657	0.00223	CcSEcCtD
Neostigmine—Agitation—Doxorubicin—sarcoma	0.000656	0.00223	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000652	0.00222	CcSEcCtD
Neostigmine—Dry mouth—Epirubicin—sarcoma	0.000642	0.00219	CcSEcCtD
Neostigmine—Syncope—Doxorubicin—sarcoma	0.00064	0.00218	CcSEcCtD
Neostigmine—Anaphylactic shock—Epirubicin—sarcoma	0.00063	0.00214	CcSEcCtD
Neostigmine—Loss of consciousness—Doxorubicin—sarcoma	0.000627	0.00213	CcSEcCtD
Neostigmine—Shock—Epirubicin—sarcoma	0.000619	0.00211	CcSEcCtD
Neostigmine—Convulsion—Doxorubicin—sarcoma	0.000618	0.0021	CcSEcCtD
Neostigmine—Nervous system disorder—Epirubicin—sarcoma	0.000617	0.0021	CcSEcCtD
Neostigmine—Tachycardia—Epirubicin—sarcoma	0.000615	0.00209	CcSEcCtD
Neostigmine—Skin disorder—Epirubicin—sarcoma	0.000612	0.00208	CcSEcCtD
Neostigmine—Hyperhidrosis—Epirubicin—sarcoma	0.000609	0.00207	CcSEcCtD
Neostigmine—Arthralgia—Doxorubicin—sarcoma	0.000608	0.00207	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000604	0.00205	CcSEcCtD
Neostigmine—Dry mouth—Doxorubicin—sarcoma	0.000594	0.00202	CcSEcCtD
Neostigmine—Hypotension—Epirubicin—sarcoma	0.000588	0.002	CcSEcCtD
Neostigmine—Anaphylactic shock—Doxorubicin—sarcoma	0.000583	0.00198	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000574	0.00195	CcSEcCtD
Neostigmine—Shock—Doxorubicin—sarcoma	0.000573	0.00195	CcSEcCtD
Neostigmine—Nervous system disorder—Doxorubicin—sarcoma	0.000571	0.00194	CcSEcCtD
Neostigmine—ABCB1—myometrium—sarcoma	0.00057	0.022	CbGeAlD
Neostigmine—Insomnia—Epirubicin—sarcoma	0.000569	0.00194	CcSEcCtD
Neostigmine—Tachycardia—Doxorubicin—sarcoma	0.000569	0.00193	CcSEcCtD
Neostigmine—Skin disorder—Doxorubicin—sarcoma	0.000566	0.00193	CcSEcCtD
Neostigmine—Hyperhidrosis—Doxorubicin—sarcoma	0.000563	0.00192	CcSEcCtD
Neostigmine—BCHE—testis—sarcoma	0.000563	0.0217	CbGeAlD
Neostigmine—Dyspnoea—Epirubicin—sarcoma	0.000561	0.00191	CcSEcCtD
Neostigmine—Somnolence—Epirubicin—sarcoma	0.00056	0.0019	CcSEcCtD
Neostigmine—ABCB1—embryo—sarcoma	0.000548	0.0212	CbGeAlD
Neostigmine—Hypotension—Doxorubicin—sarcoma	0.000544	0.00185	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Epirubicin—sarcoma	0.000544	0.00185	CcSEcCtD
Neostigmine—BCHE—liver—sarcoma	0.000532	0.0206	CbGeAlD
Neostigmine—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000531	0.00181	CcSEcCtD
Neostigmine—Insomnia—Doxorubicin—sarcoma	0.000527	0.00179	CcSEcCtD
Neostigmine—Dyspnoea—Doxorubicin—sarcoma	0.000519	0.00177	CcSEcCtD
Neostigmine—Somnolence—Doxorubicin—sarcoma	0.000518	0.00176	CcSEcCtD
Neostigmine—ABCB1—seminal vesicle—sarcoma	0.000515	0.0199	CbGeAlD
Neostigmine—Gastrointestinal pain—Epirubicin—sarcoma	0.000515	0.00175	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000503	0.00171	CcSEcCtD
Neostigmine—Urticaria—Epirubicin—sarcoma	0.0005	0.0017	CcSEcCtD
Neostigmine—Abdominal pain—Epirubicin—sarcoma	0.000498	0.00169	CcSEcCtD
Neostigmine—ABCB1—hematopoietic system—sarcoma	0.000489	0.0189	CbGeAlD
Neostigmine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000476	0.00162	CcSEcCtD
Neostigmine—Hypersensitivity—Epirubicin—sarcoma	0.000464	0.00158	CcSEcCtD
Neostigmine—Urticaria—Doxorubicin—sarcoma	0.000463	0.00157	CcSEcCtD
Neostigmine—Abdominal pain—Doxorubicin—sarcoma	0.000461	0.00157	CcSEcCtD
Neostigmine—Asthenia—Epirubicin—sarcoma	0.000452	0.00154	CcSEcCtD
Neostigmine—Pruritus—Epirubicin—sarcoma	0.000445	0.00152	CcSEcCtD
Neostigmine—Diarrhoea—Epirubicin—sarcoma	0.000431	0.00147	CcSEcCtD
Neostigmine—Hypersensitivity—Doxorubicin—sarcoma	0.000429	0.00146	CcSEcCtD
Neostigmine—Asthenia—Doxorubicin—sarcoma	0.000418	0.00142	CcSEcCtD
Neostigmine—Dizziness—Epirubicin—sarcoma	0.000416	0.00142	CcSEcCtD
Neostigmine—Pruritus—Doxorubicin—sarcoma	0.000412	0.0014	CcSEcCtD
Neostigmine—BCHE—lymph node—sarcoma	0.000408	0.0158	CbGeAlD
Neostigmine—Vomiting—Epirubicin—sarcoma	0.0004	0.00136	CcSEcCtD
Neostigmine—Diarrhoea—Doxorubicin—sarcoma	0.000399	0.00136	CcSEcCtD
Neostigmine—Rash—Epirubicin—sarcoma	0.000397	0.00135	CcSEcCtD
Neostigmine—Dermatitis—Epirubicin—sarcoma	0.000397	0.00135	CcSEcCtD
Neostigmine—Headache—Epirubicin—sarcoma	0.000394	0.00134	CcSEcCtD
Neostigmine—Dizziness—Doxorubicin—sarcoma	0.000385	0.00131	CcSEcCtD
Neostigmine—Nausea—Epirubicin—sarcoma	0.000374	0.00127	CcSEcCtD
Neostigmine—Vomiting—Doxorubicin—sarcoma	0.00037	0.00126	CcSEcCtD
Neostigmine—ABCB1—uterus—sarcoma	0.00037	0.0143	CbGeAlD
Neostigmine—Rash—Doxorubicin—sarcoma	0.000367	0.00125	CcSEcCtD
Neostigmine—Dermatitis—Doxorubicin—sarcoma	0.000367	0.00125	CcSEcCtD
Neostigmine—Headache—Doxorubicin—sarcoma	0.000365	0.00124	CcSEcCtD
Neostigmine—Nausea—Doxorubicin—sarcoma	0.000346	0.00118	CcSEcCtD
Neostigmine—ABCB1—lymphoid tissue—sarcoma	0.000345	0.0133	CbGeAlD
Neostigmine—ABCB1—bone marrow—sarcoma	0.000314	0.0121	CbGeAlD
Neostigmine—ABCB1—testis—sarcoma	0.000268	0.0104	CbGeAlD
Neostigmine—ABCB1—liver—sarcoma	0.000254	0.0098	CbGeAlD
Neostigmine—ABCB1—lymph node—sarcoma	0.000194	0.00751	CbGeAlD
